Submitted by Anonymous (not verified) on 21 October 2025 - 16:34
Opinion/decision on a Paediatric investigation plan (PIP): Agamree, vamorolone, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0355/2024
Source: